Status:
NOT_YET_RECRUITING
Impact of CASP3 Gene in Chemoresistance
Lead Sponsor:
Gehad Salah El-Din shaker
Collaborating Sponsors:
Assiut University
Conditions:
Breast Cancer
Eligibility:
FEMALE
15-75 years
Brief Summary
1. This study aims to evaluate the abnormalities of CASP3 gene in chemo resistance in breast cancer by FISH technique. evaluate the abnormalities of CASP3 gene in chemo resistance in breast cancer by ...
Detailed Description
Breast cancer (BC) is the most common malignant tumor in women and the biggest threat to the health of women worldwide. Breast cancer represents a significant global health challenge: it is the most c...
Eligibility Criteria
Inclusion
- Newly diagnosed patients of breast cancer admitted to South Egypt Cancer Institute at different stages of the disease
Exclusion
- Other malignant diseases-Male breast cancer .
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06195371
Start Date
May 1 2024
End Date
December 1 2026
Last Update
February 28 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.